Key Insights

Highlights

Treatment Research

1 treatments under study, led by Fourchamber Tartrazine Patch Across 3 Body Sites

Related Conditions

Often studied with 5 related conditions

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 50/100

Termination Rate

0.0%

0 terminated out of 3 trials

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 0 completed with results

Key Signals

Data Visualizations

Phase Distribution

1Total
Early Phase 1 (1)

Trial Status

Unknown1
Withdrawn1
Not Yet Recruiting1

Clinical Trials (3)

Showing 3 of 3 trials
NCT07817277Not Yet Recruiting

Hair Changes in Females With Type 2 Diabetes Clinical and Trichoscopic Examination

NCT06800183Early Phase 1Withdrawn

Topical Tartrazine for Improved Skin Structure Visualization in Dermatology

NCT03542539Unknown

Dermoscopy in Diagnosis of Pigmentary Skin Lesions

Showing all 3 trials

Research Network

Common Treatments

  • Fourchamber Tartrazine Patch Across 3 Body Sites1

Active Sponsors

  • Assiut University1
  • Johns Hopkins University1
  • Al-Azhar University1

Top Investigators

Related Conditions

  • Optical Imaging1
  • Pigmentary Skin Lesions1
  • Diabete Mellitus1
  • Female Androgenetic Alopecia1
  • Healthy1

Activity Timeline